Scott D Kahn insider trades

Open-market stock purchases and sales by Scott D Kahn, Director at Exagen Inc, from SEC Form 4 filings since Jun 10, 2024.

Recent trades

DateStockTradeValue
Jun 9, 2026XGN Exagen IncBought (not open market)—

Companies traded

  • XGN Exagen Inc: other filings, last Jun 9, 2026

Get free alerts when Scott D Kahn files a new trade →